Bessemer Group’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,792
Closed -$26K – 2044
2023
Q4
$26K Buy
+1,792
New +$25K ﹤0.01% 1431
2023
Q1
– Sell
-1,491
Closed -$23K – 1921
2022
Q4
$23K Buy
1,491
+41
+3% +$635 ﹤0.01% 1282
2022
Q3
$22K Buy
1,450
+276
+24% +$4.57K ﹤0.01% 1341
2022
Q2
$19K Buy
+1,174
New +$20.1K ﹤0.01% 1261
2021
Q3
– Sell
-3,630
Closed -$105K – 1657
2021
Q2
$105K Hold
3,630
– – ﹤0.01% 938
2021
Q1
$95K Buy
+3,630
New +$103K ﹤0.01% 889

Other funds holding BMEZ

Bessemer Group's BMEZ Position: Q1 2024 in Review

Bessemer Group sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 1,792 shares — an estimated $26K sold.

Bessemer Group first reported a position in BMEZ in Q1 2021 and held it in 6 quarters. The position peaked at $105K in Q2 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Bessemer Group reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Bessemer Group sold 1,792 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $26K.
  • Bessemer Group first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 6 quarters.
  • Bessemer Group's BlackRock Health Sciences Trust II position peaked at $105K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Bessemer Group's 13F filing for Q1 2024, filed 13 May 2024.